3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
16
Melanoma
8
Lung Neoplasms
8
Neoplasm Metastasis
6
Colorectal Neoplasms
6
Solid Tumours
5
Neoplasms
5
Breast Neoplasms
4
Uveal Melanoma
3
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Neurofibromatosis 1
3
Colonic Neoplasms
3
Thyroid Cancer, Papillary
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Adult Solid Neoplasm
2
Thyroid Diseases
1
Thymoma
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Renal Insufficiency
1
Rectal Neoplasms
1
Optic Nerve Glioma
1
Non-small Cell Lung Cancer Metastatic
1
Neurofibrosarcoma
1
Neurofibroma, Plexiform
1
Neuroblastoma
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
Gemcitabine
34
Cisplatin
21
Capecitabine
18
Oxaliplatin
15
Leucovorin
10
Fluorouracil
10
Irinotecan
8
Erlotinib Hydrochloride
7
pembrolizumab
5
Bevacizumab
5
Radiotherapy
4
Carboplatin
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
Watchful Waiting
3
Taxes
3
Sorafenib
3
Platinum
3
Interleukin-12 Subunit p35
3
Immunohistochemistry
3
Docetaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
trifluridine tipiracil drug combination
2
tremelimumab
2
regorafenib
2
durvalumab
2
dehydroftorafur
2
Trastuzumab
2
Paclitaxel
2
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Gallbladder Neoplasms
×
AZD 6244
×
Clear all
NCT01242605
2016-05-13
ABC-04
University College, London
Phase 1
Completed
13 enrolled